Related Experiment Video
Updated: May 4, 2026

Spatio-Temporal Manipulation of Small GTPase Activity at Subcellular Level and on Timescale of Seconds in Living Cells
Published on: March 9, 2012
Plasma membrane translocation of REDD1 governed by GPCRs contributes to mTORC1 activation
Grégory Michel1, Hans W D Matthes, Muriel Hachet-Haas
1GPCRs, Pain and Inflammation Team, UMR7242, CNRS-University of Strasbourg, LabEx Medalis, 67412 Illkirch, France.
Abstract:
The mTORC1 kinase promotes cell growth in response to growth factors by activation of receptor tyrosine kinase. It is regulated by the cellular energy level and the availability of nutrients. mTORC1 activity is also inhibited by cellular stresses through overexpression of REDD1 (regulated in development and DNA damage responses). We report the identification of REDD1 in a fluorescent live-imaging screen aimed at discovering new proteins implicated in G-protein-coupled receptor signaling, based on translocation criteria. Using a sensitive and quantitative plasma membrane localization assay based on bioluminescent resonance energy transfer, we further show that a panel of endogenously expressed GPCRs, through a Ca(2+)/calmodulin pathway, triggers plasma membrane translocation of REDD1 but not of its homolog REDD2. REDD1 and REDD2 share a conserved mTORC1-inhibitory motif characterized at the functional and structural level and differ most in their N-termini. We show that the N-terminus of REDD1 and its mTORC1-inhibitory motif participate in the GPCR-evoked dynamic interaction of REDD1 with the plasma membrane. We further identify REDD1 as a novel effector in GPCR signaling. We show that fast activation of mTORC1 by GPCRs correlates with fast and maximal translocation of REDD1 to the plasma membrane. Overexpression of functional REDD1 leads to a reduction of mTORC1 activation by GPCRs. By contrast, depletion of endogenous REDD1 protein unleashes mTORC1 activity. Thus, translocation to the plasma membrane appears to be an inactivation mechanism of REDD1 by GPCRs, which probably act by sequestering its functional mTORC1-inhibitory motif that is necessary for plasma membrane targeting.
Insights
Researchers identified REDD1 as a novel effector in G-protein-coupled receptor (GPCR) signaling. GPCRs trigger REDD1 translocation to the plasma membrane, inhibiting mTORC1 activity and cell growth.
Area of Science:
- Cellular signaling
- Molecular biology
- Biochemistry
Background:
- The mechanistic target of rapamycin complex 1 (mTORC1) kinase regulates cell growth, influenced by growth factors, energy levels, and nutrient availability.
- Cellular stresses, including overexpression of REDD1 (regulated in development and DNA damage responses), inhibit mTORC1 activity.
Purpose of the Study:
- To identify novel proteins involved in G-protein-coupled receptor (GPCR) signaling using a live-imaging screen.
- To investigate the role of REDD1 in GPCR-mediated regulation of mTORC1 activity.
Main Methods:
- Fluorescent live-imaging screen to identify proteins translocating upon GPCR activation.
- Bioluminescent resonance energy transfer (BRET) assay to quantify plasma membrane localization of REDD1.
- Functional assays to assess mTORC1 activity upon REDD1 manipulation (overexpression and depletion).
Main Results:
- REDD1, but not its homolog REDD2, translocates to the plasma membrane upon activation of various GPCRs via a Ca(2+)/calmodulin pathway.
- REDD1's N-terminus and mTORC1-inhibitory motif are crucial for its dynamic interaction with the plasma membrane and GPCR-evoked translocation.
- GPCR-induced REDD1 translocation to the plasma membrane correlates with mTORC1 inhibition; REDD1 overexpression reduces mTORC1 activation, while REDD1 depletion enhances it.
Conclusions:
- REDD1 is identified as a novel effector in GPCR signaling, linking GPCR activation to mTORC1 inhibition.
- Plasma membrane translocation serves as an inactivation mechanism for REDD1, likely through sequestration of its inhibitory motif by GPCRs.
- This study reveals a new regulatory pathway where GPCRs control cell growth via REDD1-mediated mTORC1 inhibition.
More Related Videos
07:38Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
09:32Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development
Published on: June 15, 2017
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
IP3/DAG Signaling Pathway
MAPK Signaling Cascades
Enlargement of the Plasma Membrane